Syngen Biotech Co.,Ltd. (8279.TWO)
TWD 120.0
(-0.41%)
TWD 120.0
(-0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.83 Billion | 1.93 Billion | 1.47 Billion | 1.31 Billion | 1.29 Billion |
| Cost of Revenue | 1.19 Billion | 1.24 Billion | 942.92 Million | 816.02 Million | 829.34 Million |
| Gross Profit | 643.91 Million | 688.15 Million | 528.34 Million | 495.41 Million | 467.92 Million |
| Operating Expenses | 643.91 Million | 307.95 Million | 246.53 Million | 237.92 Million | 225.03 Million |
| Selling, General and Administrative Expenses | 302.88 Million | 262.63 Million | 197.01 Million | 194.5 Million | 172.08 Million |
| Research and Development Expenses | 46.75 Million | 45.32 Million | 49.51 Million | 43.41 Million | 52.94 Million |
| Other Expenses | - | 11.86 Million | 2.09 Million | 4.33 Million | - |
| Cost and Expenses | 1.54 Billion | 1.55 Billion | 1.18 Billion | 1.05 Billion | 1.05 Billion |
| Operating Income | 334.08 Million | 419.3 Million | 299.02 Million | 264.06 Million | 242.89 Million |
| Interest Expense | 8.86 Million | 5.07 Million | 3.2 Million | 2.46 Million | 3.64 Million |
| Income Tax Expense | 58.97 Million | 75.17 Million | 57.72 Million | 47.82 Million | 51.49 Million |
| Earnings before Tax | 333.8 Million | 396.41 Million | 295.49 Million | 263.37 Million | 240.25 Million |
| Net Income | 274.82 Million | 321.23 Million | 237.77 Million | 215.55 Million | 188.76 Million |
| Earnings Per Share Basic | 10.14 | 11.85 | 8.77 | 7.95 | 7.86 |
| Earnings Per Share Diluted | 10.13 | 11.84 | 8.76 | 7.94 | 7.85 |
| Weighted Average Shares Outstanding | 27.1 Million | 27.1 Million | 27.1 Million | 27.1 Million | 24.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.12 Million | 27.13 Million | 27.13 Million | 27.13 Million | 24.04 Million |
| Gross Margin | 0.35 | 0.36 | 0.36 | 0.38 | 0.36 |
| EBIT Margin | 0.24 | 0.26 | 0.26 | 0.26 | 0.24 |
| Profit Margin | 0.15 | 0.17 | 0.16 | 0.16 | 0.15 |
| EBITDA | 433.55 Million | 505.8 Million | 380.42 Million | 340.73 Million | 308.11 Million |
| Earnings Before Tax Margin | 0.18 | 0.22 | 0.20 | 0.20 | 0.19 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 555.55 Million | 515.69 Million | 467.56 Million | 1.83 Billion | 461.6 Million | 471.34 Million |
| Cost of Revenue | 350.37 Million | 332.83 Million | 302.61 Million | 1.19 Billion | 306.68 Million | 306.36 Million |
| Gross Profit | 205.18 Million | 182.85 Million | 164.94 Million | 643.91 Million | 154.91 Million | 164.98 Million |
| Operating Expenses | 107.04 Million | 111.71 Million | 91.21 Million | 349.63 Million | 90.19 Million | 92.15 Million |
| Selling, General and Administrative Expenses | - | 95.89 Million | 78.47 Million | - | 78.73 Million | 79.02 Million |
| Research and Development Expenses | - | 15.81 Million | 12.74 Million | - | 11.45 Million | 13.13 Million |
| Other Expenses | -107.04 Million | 2.2 Million | 3.44 Million | 2.29 Million | -1.84 Million | 2.32 Million |
| Cost and Expenses | 457.42 Million | 444.54 Million | 393.82 Million | 1.54 Billion | 396.87 Million | 398.51 Million |
| Operating Income | 98.13 Million | 72.72 Million | 75.93 Million | 334.08 Million | 67.3 Million | 86.08 Million |
| Interest Expense | - | 2.36 Million | 2.48 Million | 8.86 Million | 2.22 Million | 2.32 Million |
| Income Tax Expense | 19.97 Million | 13.67 Million | 11.37 Million | 58.97 Million | 14.73 Million | 14.59 Million |
| Earnings before Tax | 92.27 Million | 63.37 Million | 71.13 Million | 333.8 Million | 71.74 Million | 84.74 Million |
| Net Income | 72.3 Million | 49.7 Million | 59.75 Million | 274.82 Million | 57 Million | 70.15 Million |
| Earnings Per Share Basic | 2.67 | 1.83 | 2.20 | - | 2.10 | 2.59 |
| Earnings Per Share Diluted | 2.67 | 1.83 | 2.20 | - | 2.10 | 2.59 |
| Weighted Average Shares Outstanding | 27.06 Million | 27.16 Million | 27.1 Million | 27.1 Million | 27.1 Million | 27.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.06 Million | 27.16 Million | 27.12 Million | 27.12 Million | 27.12 Million | 27.08 Million |
| Gross Margin | 0.37 | 0.35 | 0.35 | 0.35 | 0.34 | 0.35 |
| EBIT Margin | 0.18 | 0.20 | 0.22 | - | 0.20 | 0.24 |
| Profit Margin | 0.13 | 0.10 | 0.13 | 0.15 | 0.12 | 0.15 |
| EBITDA | 98.13 Million | 100.71 Million | 102.03 Million | - | 92.82 Million | 113.72 Million |
| Earnings Before Tax Margin | 0.18 | 0.14 | 0.16 | 0.18 | 0.15 | 0.18 |
EMIL
BAYN
2393
NNCHY
BPAC3
002114